Biosimilar Research and Development Expertise
Synexa provides PK and ADA solutions for biosimilars according to a sponsor’s priorities and requirements.
Synexa provides PK and ADA solutions for biosimilars according to a sponsor’s priorities and requirements.
Synexa’s validated assay detects IgG, IgM, IgA and SARS-CoV-2 nAbs.
Discuss biomarker and bioanalytical solutions to accelerate your therapeutic pipeline
